Event-free survival and cost-effectiveness in adult acute lymphoblastic leukaemia in first remission treated with allogeneic transplantation

Bone Marrow Transplantation

Volumn 40, Issue 7, 2007, Pages 643-649

  Orsi, C ^a   Bartolozzi, B ^b   Messori, A ^a   Bosi, A ^b  

^a Azienda Ospedaliera Universitaria   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; DISEASE FREE SURVIVAL; DONOR; HUMAN; KAPLAN MEIER METHOD; LEUKEMIA REMISSION; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

BONE MARROW TRANSPLANTATION; COST-BENEFIT ANALYSIS; DISEASE-FREE SURVIVAL; HUMANS; ITALY; LEUKEMIA, LYMPHOCYTIC, ACUTE; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34648839880     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705790     Document Type: Article

References (28)

1. Gupta V, Yi QL, Brandwein J, Minden MD, Schuh AC, Wells RA et al. The role of allogeneic bone marrow transplantation in adult patients below theage of 55 years with acute lymphoblastic leukemia in first complete remission: A donor vs no-donor comparison. Bone Marrow Transplant 2004; 33: 397-404.
2. Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075-4086.
3. Ribera JM, Oriol A, Bethencourt C, Parody R, Hernandez-Rivas JM, Moreno MJ et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica 2005; 90: 1346-1356.
4. Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: An evidence-based review. Biol Blood Marrow Transplant 2006; 12 1-30.
5. Yanada M, Matsuo K, Suzuki T, Naoe T. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukaemia- a metaanalysis. Cancer 2006; 106: 2657-2663.
6. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: Is there a difference? Lancet 1993; 341: 418-422.
7. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs individual patient data: Paternal cell immunization for recurrent miscarriage. JAMA 1995; 274: 830-836.
8. Steinberg KK, Smith SJ, Stroup DF, Olkin I, Lee NC, Williamson GD et al. Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies. Am J Epidemiol 1997; 145: 917-925.
9. Oxman AD, Clarke MJ, Stewart LA. From science to practice: Meta-analysis using individual patient data are needed. JAMA 1995; 274: 845-846.
10. Messori A, Rampazzo R. Meta-analysis of clinical trials based on censored end-points: Simplified theory and implementation of the statistical algorithms on a microcomputer. Comput Methods Programs Biomed 1993; 40: 261-267.
11. Messori A, Bosi A, Bacci S, Lazlo D, Trippoli S, Locatelli F et al. Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Bone Marrow Transplant 1999; 23: 489-495.
12. Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993; 71: 2585-2592.
13. Trallori G, Messori A, Scuffi C, Bardazzi G, Silvano R, D'Albasio G et al. Effectiveness of 5-aminosalicylic acid enemas for maintaining remission in patients with left-sided ulcerative colitis: A meta- and economic analysis. J Clin Gastroenterol 1995; 20: 257-259.
14. Messori A, Brignola C, Trallori G, Rampazzo R, Bardazzi G, Belloli C et al. Effectiveness of 5-aminosalicylic acid (5-ASA) for maintaining remission in patients with Crohn's disease: A meta-analysis. Am J Gastroenterol 1994; 89: 692-698.
15. Bardelli F, Messori A, Rampazzo R, Alberti A, Martini N. Effect of recombinant or lymphoblastoid alpha interferon on ALT in patients with chronic hepatitis C or chronic non-A non-B hepatitis: A meta-analysis. Clin Drug Invest 1995; 9: 239-254.
16. Ferrandina G, Scambia G, Bardelli F, Benedetti Panici P, Mancuso S, Messori A. Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: A meta-analysis. Br J Cancer 1997; 76: 661-666.
17. Messori A, Trippoli S, Becagli P, Zaccara G. Cost-effectiveness of riluzole in amyotrophic lateral sclerosis. Pharmaco-economics 1999; 16: 153-163.
18. Messori A, Trippoli S, Vaiani M, Cattel F. Survival meta-analysis of individual patient data and suvival meta-analysis of published (aggregate) data. Clin Drug Invest 2000; 20: 309-313.
19. Labar B, Suciu S, Zittoun R, Muus P, Marie JP, Fillet G et al. Allogencic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients
20. Hallbook H, Hagglund H, Stockelberg D, Nilsson PG, Karlsson K, Bjorkholm M et al. Autologous and allogeneic stem cell transplantation in adult ALL: The Swedish adult ALL group experience. Bone Marrow Transplant 2005; 35: 1141-1148.
21. Hunault M, Harousseau JL, Delain M, Truchan-Graczykm M, Chan JY, Witz F et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: A GOELAMS trial. Blood 2004; 104: 3028-3037.
22. Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X et al. Outcome of treatment in adults with Philadelphia chromosome - positive acute lymphoblastic leukemia - results of the prospective multicenter LALA-94 trial. Blood 2002; 100: 2357-2366.
23. Mishra V, Vaaler S, Brinch L. A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures. Bone Marrow Transplant 2001; 28: 1111-1116.
24. Lee SJ, Klar N, Weeks JC, Antin JH. Predicting costs of stem-cell transplantation. J Clin Oncol 2000; 18: 64-71.
25. van Agthoven M, Groot MT, Verdonck LF, Löwenberg B, Schattenberg AVMB, Oudshoorn M et al. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia. Bone Marrow Transplant 2002; 30: 243-251.
26. Yu YB, Gan JP, You JY, Chern HH, Chau WK, Tzeng CH et al. Cost-effectiveness of postremission intensive therapy in patients with acute leukaemia. Ann Oncol 2007; 18: 529-534.
27. Messori A, Trippoli S, Vaiani M. Efficacy, safety, and cost of new anticancer drugs. Price needs to be evaluated against effectiveness. BMJ 2002; 325: 1302.
28. Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995; 332: 1418-1424.